Asian Bond Fund

Total Page:16

File Type:pdf, Size:1020Kb

Asian Bond Fund EASTSPRING INVESTMENTS - ASIAN BOND FUND December 2020 eastspring.us/eastspring.comoffshoreadvisor 2 LEADING ASSET MANAGER IN ASIA LEVERAGING OUR ASIAN DNA TO CAPITALISE ON GLOBAL OPPORTUNITIES 1994 USD 248bn 300+ INVESTMENT One of the DEEP INSIGHTS Founded 1994 in Managing USD 248bn PROFESSIONALS^ LARGEST INTO ASIA Singapore (HQ) and assets on behalf of Unrivalled on-the-ground ASIAN ASSET 100% owned by institutional and individual Our investment teams' investment presence in Asia Prudential plc (UK) investors globally MANAGERS deep understanding of Asian markets, provides us and a major Asian Fixed with a unique perspective Income player for global investments United Kingdom Luxembourg Japan United States China* South Korea Taiwan India* Hong Kong* Thailand* Vietnam Malaysia Singapore Indonesia Investment and Sales & Client Service office Sales & Client Service Office Joint venture Source: Eastspring Investments. As at 31 December 2020. ^Including joint ventures and sales offices in the US, UK and Luxembourg. AUM size by contracted sales. Note: bn = billion. STRICTLY PRIVATE AND CONFIDENTIAL. FOR PROFESSIONAL INVESTORS ONLY. 3 A DIVERSIFIED AND GROWING GLOBAL ASSET MANAGER AUM Growth (USD bn) 2% 7% 241 248 193 47% 12% CAGR 188 40% 146 131 99 121 95 81 78 51% Fixed Income Equity Quant Others ^ Investment Solutions (IS) 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Internal Life 56% Third Party 44% AUM USD248bn Source: Eastspring Investments as at 31 December 2020. AUM includes Joint Ventures AUM based on % of ownership *Joint ventures: India - ICICI Prudential Asset Management Co Ltd, Hong Kong - Bank of China International – Prudential Asset Management and China - CITIC-Prudential Fund Management Co Ltd. ^ Others – include Alternative assets and money market funds. Note: bn = billion. STRICTLY PRIVATE AND CONFIDENTIAL. FOR PROFESSIONAL INVESTORS ONLY. 4 EXTENSIVE LOCAL PRESENCE IN ASIA ONSHORE ASSET MANAGEMENT ACROSS ASIA Sources: Singapore and Hong Kong (Morningstar), Malaysia (Lipper), Thailand (Association of Investment Management Companies), Korea (Korea Financial Investment Association), India (Association of Mutual Funds in India), Japan (Investment Trusts Association, Japan), Taiwan (Securities Investment Trust & Consulting Association of R.O.C.), China (Wind), Indonesia (Otoritas Jasa Keuangan), Vietnam (State Securities Commission of Vietnam). All markets as of December 2020. Eastspring JVs include HK, India and China. Japan reflects Publicly Offered Investment Trusts market presence. China reflects public mutual funds market presence. Vietnam reflects open-ended mutual funds market presence only. *Market presence based on whether the AMCs offer onshore domiciled mutual funds. Market ranking based on 100% shareholdings. STRICTLY PRIVATE AND CONFIDENTIAL. FOR PROFESSIONAL INVESTORS ONLY. 5 INVESTMENT CAPABILITIES OVERVIEW Fixed Investment Quantitative Equities Income Solutions Strategies AUM of AUM of AUM of AUM of USD 25bn USD 62bn USD 115bn* USD 3.5bn Key capabilities: Key capabilities: Key capabilities: Key capabilities: GEM Concentrated Value EM Debt Multi Asset Global Low Vol Japan Concentrated Value Asian HY Solutions Asian Low Vol China A Growth Asia Fixed Income Multi-Factor Greater China Asian Sustainable Asia ex – Japan China RMB Number of Inv. Number of Inv. Number of Inv. Number of Inv. professionals: 31 professionals: 22 professionals: 12 professionals: 8 Avg. yrs experience: Avg. yrs experience: Avg. yrs experience: Avg. yrs experience: 18 15 14 13 Source: Eastspring Investments as at 31 December 2020. AUM for investment teams are internally calculated and includes advisory mandates. There might be double counting of assets within the individual investment teams. The figures above do not reflect joint venture assets under management. *Including sub-funds managed by other teams and investments into Eastspring SICAV funds. Note: bn = billion. STRICTLY PRIVATE AND CONFIDENTIAL. FOR PROFESSIONAL INVESTORS ONLY. 6 FOCUSED - FIXED INCOME INVESTMENT CAPABILITIES Strategy Name Asian High Yield Bond China Onshore Bond Global Emerging Markets Bond JPMorgan Asia Credit – Non Benchmark JPMorgan Emerging Markets Bond Index - Investment Grade Index Markit iBoxx ALBI China Onshore Bond index Global Diversified Invests primarily in USD– Invests primarily in China onshore bonds Invests primarily in hard currency denominated below investment across different sectors, including government Investment Objective grade bonds issued by Asian denominated bonds issued by government corporate, quasi-sovereign and and non-government bond sectors; Moderate and quasi-government entities within sovereign flexibility to go into non-RMB securities Emerging Markets Investment Style Benchmark-aware Benchmark-unconstrained Benchmark-aware AuM (USD mn) 468.3 434.2 2,251.6 Incepted :December 2019 Strategy Inception Oct 2011 Investment Start Date : Apr 2011 21 February 2020 Lead PM Wai Mei Leong Guan Yi Low with advisory from China WFOE Eric Fang Current YTM (%)+ 7.72 3.37 4.29 Current Duration (yrs)+ 3.50 5.45 8.44 Credit Quality Bias High Yield Investment Grade High Yield Key Investment Parameters * Duration Range +/- 1.5 years from BM duration N/A +/- 1 year from BM duration Not applicable; Max 20%in non-BM Max Country Weight countries Up to 35% for single country of risk ex. China +/- 5% BM Weight Max 20% in corporates (ex Quasi- Max Sector Weight Max 33% in IG, non-rated and cash N/A sovereigns) Up to 10% per currency with exception of Currency Limits Max 20% in non-USD exposures CNY/CNH; Max aggregate non-CNY/CNH Max 10% in non-USD exposures exposure: 30% Min. Portfolio Average Not more than 3 notches below BM Aggregate non-investment grade bond exposure Not more than 1 notch below BM rating Credit Rating* rating (Linear) limit: Max 30% (Linear) Source: Eastspring Investments, as of 31 December 2020. +The computation of yield to maturity and average duration includes cash and derivatives securities.; * Internal guidelines, subject to changes at fund managers’ discretion STRICTLY PRIVATE AND CONFIDENTIAL. FOR PROFESSIONAL INVESTORS ONLY. 7 FOCUSED - FIXED INCOME INVESTMENT CAPABILITIES Strategy Name Asian USD Bond Asia Sustainable Bond Asian Total Return Benchmark JPMorgan Asia Credit Index Unconstrained Unconstrained Invests in a mix of green, social and sustainability Invests primarily in USD –denominated (“GSS”) bonds and other debt securities issued by Invests primarily in a mix of USD and bonds issued by Asian corporate, quasi- Emerging Asian governments, quasi-governments, Investment Objective domestic Asian bonds and currencies; sovereign and sovereign, including both corporates or supranational, which are aligned to flexibility to implement tactical high yield and investment grade internal Environmental, Social and Governance overlays (“ESG”) principles Investment Style Benchmark-aware Absolute return targeted Absolute return targeted AuM (USD mn) 3,334.2 73.3 92.7 Strategy Inception Dec 2002 Dec 2019 Nov 2017 Lead PM Wai Mei Leong Rong Ren Goh Guan Yi Low Current YTM (%)+ 4.43 4.20 6.27 Current Duration (yrs)+ 5.57 4.39 4.00 Credit Quality Bias Investment Grade Investment Grade Investment Grade Key Investment Parameters * Duration Range +/- 1 year from BM duration Below 5 years -1y to 8y Max Country Weight +/- 10% BM Weight 35% 30% Sovereign: Max 35% for single issuer Max non-investment grade Max Sector Weight Not applicable IG/HY Corporate: Max 10% for single issuer exposure: 30% Up to 10% per currency with exception of USD Currency Limits Max 10% in non-USD exposures (subject to an aggregate limit of 20% for non-USD Aggregate net short FX: 30% exposures) Min. Portfolio Average Not more than 1 notch below BM rating Max non-investment grade N.A. Credit Rating* (Linear) exposure: 30% Source: Eastspring Investments, as of 31 December 2020. +The computation of yield to maturity and average duration includes cash and derivatives securities.; * Internal guidelines, subject to changes at fund managers’ discretion STRICTLY PRIVATE AND CONFIDENTIAL. FOR PROFESSIONAL INVESTORS ONLY. 8 AWARD WINNING FIXED INCOME CAPABILITIES 2020 2019 2018 2017 Asian Local Asian Asian Asian High Yield Bond Currency Bond Bond Bond House House Fund Fund “Best of the Best” “Best of the Best” Best Fund over five years Best Fund Manager Bond Asia Regional Awards Regional Awards Bond USD – High Yield Pacific Local Currency Category (Awarded by Asia Asset (Awarded by Asia Asset Category Low Guan Yi Management) Management) (Awarded by Refinitiv Lipper Fund (Awarded by Citywire Asia) Award) Top 5 Investment Houses in Asia Asian Local – Asian Local Bond Currency Singapore Asian Local st Currency Category Rank 1 Select Bond Currency (Awarded by The Asset Benchmark Bond Bond Research) Fund Fund Fund Most Astute Investors Asian Local Bond Currency Best Asian Fixed Income Fund, Best Fund over 3 & 5 years Portfolio managers, Local Currency Bond SGD Top 5 Investment Houses in Cheong Wei Ming (No. 3), (Awarded by Asia Asset Management) (Awarded by Refinitiv Lipper Fund Asia – Asian Local Bond Danny Tan (No. 6) and Guan Yi st Award) Currency Category Rank 1 Low (Highly commended) (Awarded by The Asset Benchmark (Awarded by The Asset Benchmark Research) Research) Sources: Refinitiv Lipper (April 2019 and April 2017), Citywire (April 2016), The Asset Benchmark Research (November 2016, July 2017), Asia Asset Management (2015, 2019 and 2020), Asian Investor Asset Management (June 2015), and unless otherwise stated. STRICTLY PRIVATE AND CONFIDENTIAL. FOR PROFESSIONAL
Recommended publications
  • US and International Responses to the Global Spread of Avian
    Order Code RL33219 CRS Report for Congress Received through the CRS Web U.S. and International Responses to the Global Spread of Avian Flu: Issues for Congress Updated February 23, 2006 Tiaji Salaam-Blyther and Emma Chanlett-Avery Coordinators Foreign Affairs, Defense, and Trade Division Congressional Research Service ˜ The Library of Congress U.S. and International Responses to the Global Spread of Avian Flu: Issues for Congress Summary One strain of avian influenza currently identified in Asia, Europe, the Middle East, and Africa is known as Influenza A/H5N1. Although it is a bird flu, it has infected a relatively small number of people — killing around 50% of those infected. Some scientists are concerned that H5N1 may cause the next influenza pandemic. Flu pandemics have occurred cyclically, between every 30 and 50 years. Since 1997, when the first human contracted H5N1 in Hong Kong, the virus has resurfaced and spread to more than a dozen countries in Asia and eastern Europe — infecting more than 170 people and killing more than 90. In February 2006, the virus spread further to countries in western Europe. That month, officials confirmed that birds in Austria, Germany, Greece, and Italy were infected with the virus. Health experts are investigating suspected bird cases in France. The first human H5N1 fatalities outside of Asia occurred in 2006 when Turkey and Iraq announced their first human deaths related to H5N1 infection in January 2006 and February 2006, respectively. A global influenza pandemic could have a number of consequences. Global competition for existing vaccines and treatments could ensue. Some governments might restrict the export of vaccines or other supplies in order to treat their own population.
    [Show full text]
  • Recent Articles from the China Journal of System Engineering Prepared
    Recent Articles from the China Journal of System Engineering Prepared by the University of Washington Quantum System Engineering (QSE) Group.1 Bibliography [1] Mu A-Hua, Zhou Shao-Lei, and Yu Xiao-Li. Research on fast self-adaptive genetic algorithm and its simulation. Journal of System Simulation, 16(1):122 – 5, 2004. [2] Guan Ai-Jie, Yu Da-Tai, Wang Yun-Ji, An Yue-Sheng, and Lan Rong-Qin. Simulation of recon-sat reconing process and evaluation of reconing effect. Journal of System Simulation, 16(10):2261 – 3, 2004. [3] Hao Ai-Min, Pang Guo-Feng, and Ji Yu-Chun. Study and implementation for fidelity of air roaming system above the virtual mount qomolangma. Journal of System Simulation, 12(4):356 – 9, 2000. [4] Sui Ai-Na, Wu Wei, and Zhao Qin-Ping. The analysis of the theory and technology on virtual assembly and virtual prototype. Journal of System Simulation, 12(4):386 – 8, 2000. [5] Xu An, Fan Xiu-Min, Hong Xin, Cheng Jian, and Huang Wei-Dong. Research and development on interactive simulation system for astronauts walking in the outer space. Journal of System Simulation, 16(9):1953 – 6, Sept. 2004. [6] Zhang An and Zhang Yao-Zhong. Study on effectiveness top analysis of group air-to-ground aviation weapon system. Journal of System Simulation, 14(9):1225 – 8, Sept. 2002. [7] Zhang An, He Sheng-Qiang, and Lv Ming-Qiang. Modeling simulation of group air-to-ground attack-defense confrontation system. Journal of System Simulation, 16(6):1245 – 8, 2004. [8] Wu An-Bo, Wang Jian-Hua, Geng Ying-San, and Wang Xiao-Feng.
    [Show full text]
  • Detection Technologies, Part 2
    www.engineeringvillage.com Citation results: 500 Downloaded: 4/24/2020 1. RESPIRATORY NITRIC OXIDE METER MAULT JAMES R Assignee: HEALTHETECH INC Publication Number: WO126547 Publication date: 06/07/2001 Kind: CORRECTED TITLE PAGE OF AN EP-A DOCUMENT Database: WO Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 2. RESPIRATORY NITRIC OXIDE METER MAULT JAMES R Assignee: HEALTHETECH INC Publication Number: WO126547 Publication date: 04/19/2001 Kind: Patent Application Publication Database: WO Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 3. RESPIRATORY THERAPY APPARATUS AND METHODS KHASAWNEH, Mohammad, Qassim, Mohammad; SAGOO, Jeevan; VARNEY, Mark, Sinclair Assignee: SMITHS MEDICAL INTERNATIONAL LIMITED Publication Number: WO2015036723 Publication date: 03/19/2015 Kind: Patent Application Publication Database: WO Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 4. RESPIRATORY THERAPY APPARATUS AND METHODS BENNETT, Paul James Leslie Assignee: SMITHS MEDICAL INTERNATIONAL LIMITED Publication Number: WO2014202923 Publication date: 12/24/2014 Kind: Patent Application Publication Database: WO Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 5. RESPIRATORY THERAPY APPARATUS AND METHODS Khasawneh, Mohammad Qassim Mohammad; Sagoo, Jeevan; Varney, Mark Sinclair Assignee: SMITHS MEDICAL INTERNATIONAL LIMITED Publication Number: US20160213868 Publication date: 07/28/2016 Kind: Patent Application Publication Database: US Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V. Data Provider: Engineering Village 6. RESPIRATORY THERAPY APPARATUS AND METHODS BENNETT, Paul James Leslie Assignee: Smiths Medical International Limited Publication Number: EP3010396 Publication date: 04/27/2016 Kind: Patent Application Publication Database: EP Patents Compilation and indexing terms, 2020 LexisNexis Univentio B.V.
    [Show full text]
  • Lyle Fearnley-Dissertation-11-26-2013 1
    Life at the Influenza Epicentre: Transactions of Global Health and Animal Disease in Contemporary China By Lyle Arthur Fearnley A dissertation submitted in partial satisfaction of the requirements for the degree of Joint Doctor of Philosophy with University of California, San Francisco in Medical Anthropology in the Graduate Division of the University of California, Berkeley Committee in Charge: Professor Paul Rabinow, Chair Professor Xin Liu Professor Dorothy Porter Professor Massimo Mazzotti Fall 2013 Abstract Life at the Influenza Epicenter: Transactions of Global Health and Animal Disease in Contemporary China By Lyle Arthur Fearnley Joint Doctor of Philosophy in Medical Anthropology with University of California, San Francisco University of California, Berkeley Professor Paul Rabinow, Chair This thesis is an anthropological study of the making of global health on China's grounds, based on inquiry into the health programs assembled around China's poultry sector amidst outbreaks of avian influenza. Influenza pandemics are global in scale, but since the 1960s flu experts have hypothetically located the origin, or "epicenter," of flu pandemics in southern China. Drawing on extensive fieldwork among flu experts, Chinese veterinarians, and farmers, the thesis describes how the farmed ecology of Poyang Lake in southern China is being studied as a possible epicenter of influenza emergence. As global dangers are attributed to specific Chinese environments and agricultural practices, I follow flu experts as they move from the laboratory to the field and as they shift their scientific object from the sequence to the ecosystem. This movement outside the laboratory is also a movement onto China's grounds, a motion that I argue raises three anthropological problems.
    [Show full text]
  • 54Th Annual Commencement 54TH
    54th Annual Commencement 54TH Brilliant Future Juris Doctor Degrees MAY 11 Doctor of Medicine Degrees JUNE 1 Master of Fine Arts and Doctoral Degrees JUNE 15 Master’s and Baccalaureate Degrees JUNE 14, 15, 16, 17 Table of Contents 2019 Commencement Schedule of Ceremonies . 3 Chancellor’s Award of Distinction . 4 Message from the Chancellor . 5 Message from the Interim Vice Chancellor, Student Affairs . 6 Deans’ Messages & Ceremonies Claire Trevor School of the Arts. 7-8 School of Biological Sciences . 9-10 The Paul Merage School of Business . 11-12 School of Education . .13-14 Samueli School of Engineering . .15-16 Susan and Henry Samueli College of Health Sciences . 17-21 School of Medicine . 18, 20 Sue & Bill Gross School of Nursing . 18, 21 Department of Pharmaceutical Sciences . .19, 21 Program in Public Health . .19, 21 School of Humanities . 22-23 Donald Bren School of Information & Computer Sciences . 24-25 School of Law . 26-27 School of Physical Sciences . .28-29 School of Social Ecology . 30-31 School of Social Sciences . 32-33 Graduate Division . .34-35 List of Graduates Advanced Degree Candidates . 36 Undergraduate Degree Candidates Claire Trevor School of the Arts. 47 School of Biological Sciences . .48 The Paul Merage School of Business . 52 School of Education . 54 The Henry Samueli School of Engineering . 55 School of Humanities . .60 Donald Bren School of Information & Computer Sciences . 63 Sue & Bill Gross School of Nursing . 67 Department of Pharmaceutical Sciences . 67 School of Physical Sciences . 68 Program in Public Health . 70 School of Social Ecology . 73 School of Social Sciences .
    [Show full text]
  • China Perspectives, 2007/4 | 2007 Karl Taro Greenfeld, China Syndrome
    China Perspectives 2007/4 | 2007 China and its Past: Return, Reinvention, Forgetting Karl Taro Greenfeld, China Syndrome. The True Story of the 21st Century's First Great Epidemic; Thomas Abraham, Twenty-First Plague. The Story of SARS. Frédéric Keck Édition électronique URL : http://journals.openedition.org/chinaperspectives/2763 DOI : 10.4000/chinaperspectives.2763 ISSN : 1996-4617 Éditeur Centre d'étude français sur la Chine contemporaine Édition imprimée Date de publication : 15 décembre 2007 ISSN : 2070-3449 Référence électronique Frédéric Keck, « Karl Taro Greenfeld, China Syndrome. The True Story of the 21st Century's First Great Epidemic; Thomas Abraham, Twenty-First Plague. The Story of SARS. », China Perspectives [En ligne], 2007/4 | 2007, mis en ligne le 09 avril 2008, consulté le 23 septembre 2020. URL : http:// journals.openedition.org/chinaperspectives/2763 ; DOI : https://doi.org/10.4000/chinaperspectives. 2763 Ce document a été généré automatiquement le 23 septembre 2020. © All rights reserved Karl Taro Greenfeld, China Syndrome. The True Story of the 21st Century's Fir... 1 Karl Taro Greenfeld, China Syndrome. The True Story of the 21st Century's First Great Epidemic; Thomas Abraham, Twenty-First Plague. The Story of SARS. Frédéric Keck 1 The SARS crisis in 2003 very quickly gave rise to a number of analyses on its consequences in terms of public health by setting China and the World Health Organisation (WHO) if in opposition to each other in a global and quite general way1. Few accounts, however, take into consideration the plurality of the actors who were involved in this crisis, the brevity of which (a few months between December 2002 and April 2003) disguises somewhat the intensity of the efforts to bring it to an end.
    [Show full text]
  • 2005 REPORT to CONGRESS of the U.S.-CHINA ECONOMIC and SECURITY REVIEW COMMISSION
    2005 REPORT TO CONGRESS of the U.S.-CHINA ECONOMIC AND SECURITY REVIEW COMMISSION ONE HUNDRED NINTH CONGRESS FIRST SESSION NOVEMBER 2005 Printed for the use of the U.S.-China Economic and Security Review Commission Available via the World Wide Web: http://www.uscc.gov 1 2005 REPORT TO CONGRESS of the U.S.-CHINA ECONOMIC AND SECURITY REVIEW COMMISSION ONE HUNDRED NINTH CONGRESS FIRST SESSION NOVEMBER 2005 Printed for the use of the U.S.-China Economic and Security Review Commission Available via the World Wide Web: http://www.uscc.gov U.S. GOVERNMENT PRINTING OFFICE WASHINGTON : 2005 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2250 Mail: Stop SSOP, Washington, DC 20402–0001 U.S.-CHINA ECONOMIC AND SECURITY REVIEW COMMISSION Hall of the States, Suite 602 444 North Capitol Street, NW Washington, DC 20001 Phone: (202) 624–1407 Fax: (202) 624–1406 E-mail: [email protected] www.uscc.gov COMMISSIONERS Hon. C. RICHARD D’AMATO, Chairman ROGER W. ROBINSON, Jr., Vice Chairman CAROLYN BARTHOLOMEW, Commissioner Hon. PATRICK A. MULLOY, Commissioner GEORGE BECKER, Commissioner Hon. WILLIAM A. REINSCH, Commissioner STEPHEN D. BRYEN, Commissioner Hon. FRED D. THOMPSON, Commissioner THOMAS DONNELLY, Commissioner MICHAEL R. WESSEL, Commissioner JUNE TEUFEL DREYER, Commissioner LARRY M. WORTZEL, Commissioner T. SCOTT BUNTON, Executive Director KATHLEEN J. MICHELS, Associate Director The Commission was created in October 2000 by the Floyd D. Spence Na- tional Defense Authorization Act for 2001 sec. 1238, Public Law 106– 398, 114 STAT.
    [Show full text]
  • APICAL M2 PROTEIN IS REQUIRED for EFFICIENT INFLUENZA a VIRUS REPLICATION by Nicholas Wohlgemuth a Dissertation Submitted To
    APICAL M2 PROTEIN IS REQUIRED FOR EFFICIENT INFLUENZA A VIRUS REPLICATION by Nicholas Wohlgemuth A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland October, 2017 © Nicholas Wohlgemuth 2017 All rights reserved ABSTRACT Influenza virus infections are a major public health burden around the world. This dissertation examines the influenza A virus M2 protein and how it can contribute to a better understanding of influenza virus biology and improve vaccination strategies. M2 is a member of the viroporin class of virus proteins characterized by their predicted ion channel activity. While traditionally studied only for their ion channel activities, viroporins frequently contain long cytoplasmic tails that play important roles in virus replication and disruption of cellular function. The currently licensed live, attenuated influenza vaccine (LAIV) contains a mutation in the M segment coding sequence of the backbone virus which confers a missense mutation (alanine to serine) in the M2 gene at amino acid position 86. Previously discounted for not showing a phenotype in immortalized cell lines, this mutation contributes to both the attenuation and temperature sensitivity phenotypes of LAIV in primary human nasal epithelial cells. Furthermore, viruses encoding serine at M2 position 86 induced greater IFN-λ responses at early times post infection. Reversing mutations such as this, and otherwise altering LAIV’s ability to replicate in vivo, could result in an improved LAIV development strategy. Influenza viruses infect at and egress from the apical plasma membrane of airway epithelial cells. Accordingly, the virus transmembrane proteins, HA, NA, and M2, are all targeted to the apical plasma membrane ii and contribute to egress.
    [Show full text]
  • A Longitudinal Cohort of Randomly Sampled Weibo Users Yuner Zhu, MA; King-Wa Fu, Phd; Karen A
    BRIEF REPORT Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January–February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users Yuner Zhu, MA; King-Wa Fu, PhD; Karen A. Grépin, PhD; Hai Liang, PhD; Isaac Chun-Hai Fung, PhD ABSTRACT Objective: Awareness and attentiveness have implications for the acceptance and adoption of disease prevention and control measures. Social media posts provide a record of the public’s attention to an outbreak. To measure the attention of Chinese netizens to coronavirus disease 2019 (COVID-19), a pre-established nationally representative cohort of Weibo users was searched for COVID-19-related key words in their posts. Methods: COVID-19-related posts (N = 1101) were retrieved from a longitudinal cohort of 52 268 randomly sampled Weibo accounts (December 31, 2019–February 12, 2020). Results: Attention to COVID-19 was limited prior to China openly acknowledging human-to-human transmis- sion on January 20. Following this date, attention quickly increased and has remained high over time. Particularly high levels of social media traffic appeared around when Wuhan was first placed in quarantine (January 23–24, 8–9% of the overall posts), when a scandal associated with the Red Cross Society of China occurred (February 1, 8%), and, following the death of Dr Li Wenliang (February 6–7, 11%), one of the whis- tleblowers who was reprimanded by the Chinese police in early January for discussing this outbreak online. Conclusion: Limited early warnings represent missed opportunities to engage citizens earlier in the out- break. Governments should more proactively communicate early warnings to the public in a transparent manner.
    [Show full text]
  • Appendix 3 (As Supplied by the Authors): Excluded Articles by Level and Question
    Appendix 3 (as supplied by the authors): Excluded articles by level and question Level 1: Title and Abstract Screening 49(4), 506 A Cecille, M J Wendling, O Panabieres, J P Gut 1. Is it or does it include an original (1999//). [Retrospective study of the value of the validation study of a blood-based RIBA-3 test in 68 patients with discordant qualitative immunoassay for hepatitis serologies with regard to hepatitis C obtained with C? (Exclude rapid/point-of-care tests, third generation ELISA tests. Is there still a value in geno/serotyping tests, tests applied to RIBA-3?]. Pathologie-biologie, 47(5), 508 dried blood or saliva.) A D Shannon, C Morrissy, S G Mackintosh, H A Westbury (1993//). Detection of hog cholera virus A Alberti, G Morsica, L Chemello, D Cavalletto, F antigens in experimentally-infected pigs using an Noventa, P Pontisso, A Ruol (1992//). Hepatitis C antigen-capture ELISA. Veterinary microbiology, viraemia and liver disease in symptom-free 34(3), 233 individuals with anti-HCV. Lancet (London, England), 340(8821), 697 A Diez, J A Quiroga, M Melero, G Moraleda, I Castillo, J C Porres, V Carreno (1991//). A Antico, S Platzgummer, D Bassetti, N Bizzaro, Detection of antibody to calmodulin in chronic viral R Tozzoli, D Villalta,Study Group on hepatitis: lack of correlation with virus replication Autoimmune Diseases of the Italian Society of and hepatocellular damage. Digestion, 49(3), 125 Laboratory Medicine (SIMeL) (2010//). Diagnosing systemic lupus erythematosus: new- A E Silva, B Hosein, R W Boyle, C T Fang, M generation immunoassays for measurement of Shindo, J G Waggoner, J H Hoofnagle, A M Di anti-dsDNA antibodies are an effective alternative Bisceglie (1994//).
    [Show full text]
  • An Ethnographical Study of Avian Influenza
    CHAPTER TWO Monitoring Animals, Preparing Humans: An Ethnographical Study of Avian Influenza Frédéric Keck What are the conditions for carrying out an ethnography of avian influenza? The anthropologist who studies this phenomenon must simultaneously follow the rules of what George Marcus has termed “a multi-sited ethnography in/of the world system” and engage in what Stefan Helmreich has described as “multispecies ethnography.”1 The study of flu viruses and of the microbiologists who hunt them does indeed entail crossing biological (in moving from one cell or animal species to the next) and political borders (in moving from Paris to Geneva, Mexico City to New York, Guangzhou to Hong Kong, and Tokyo to Phnom Penh). I have chosen to employ the ethnographic “I” in order to gather these actors of varying sizes and ontologies, who together constitute what I call a “world with flu.”2 This does not mean that this world is solely an artifact of the ethnographical study itself; in fact, it first emerged a half century ago concomitantly with the flu virus surveillance networks that were set up around the world in anticipa- tion of a return of the 1918 pandemic. Hong Kong, where I carried out my fieldwork, had the particularity of being the place where H5N1, a very lethal virus that moves from birds to humans, was first identified in 1997. With the advent of H1N1 in 2009, an eventuality for which the territory had spent the preceding 15 years preparing, Hong Kong thus seemed to offer an excellent vantage point for taking an informed look at the global mobilization to fight the virus.
    [Show full text]
  • Curriculum Vitae of Nan-Shan ZHONG Professor Director of State Key
    Curriculum Vitae of Nan-Shan ZHONG Professor Director of State Key Laboratory of Respiratory Disease in Guangzhou Director of Guangzhou Institute of Respiratory Disease Professor Nanshan Zhong is a Medical Professor of Guangzhou Medical College, and a supervisor of respiratory medicine doctoral candidates. He graduated from Beijing Medical College, majoring in medical sciences. At present, he holds the posts of the Chairman of Guangzhou Association for Science & Technology, Director of Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital of Guangzhou Medical College, and Director-general of China State Key Laboratory of Respiratory Diseases. Professor Zhong is also a leader and principal investigator to more than 10 major scientific projects, including the State-973, State-863, Tenth State Five-year Plan, National Nature Science Grants, and WHO/GOLD global network. He has published a great number of papers in worldwide reputed SCI journals, including those in Nature Medicine, Lancet, BMJ, Am J Respir Crit Care Med, and more than 200 papers in State-level journals. His publications have received 438 citations. Besides, he has published 16 monographs including Respiratory Medicine (National College Textbooks for Medical Postgraduates), Medicine (National textbooks), Asthma: From Basic to Clinical, etc, and has gained 9 patents. Over the past decades, Prof Zhong has been a leader scientist in promoting China’s respiratory medicine towards the forefront of international advances. He first developed and refined the definition of asymptomatic asthma, later cited by WHO, through his originally designed “simple bronchial provocation test" and epidemiological surveys. In a systemic review of etiology of chronic cough in China, he elucidated the neuroinflammatory mechanisms to gastroesophageal reflux induced cough.
    [Show full text]